Product Introduction
An integrated radiopharmaceutical platform based on a high-energy, high-current electron accelerator, connecting the full chain capabilities of 'accelerator + target station + separation and purification'.
High-energy intense electron accelerator
Core components are independently developed, achieving stable output at the 200 kW level.
High-Power Target Station System
High-load target components and fast heat exchange structures support continuous production.
GMP-grade separation and purification
The multi-stage separation process ensures the purity and consistency of radionuclides, meeting medical standards.
Core Nuclear Capabilities
Focus on deploying high-value radionuclides such as Ac-225, Cu-67, Sc-47, and Mo-99 to meet the needs of both diagnostic and therapeutic applications.
Platform Advantages
Stable production capacity
The modular system supports quick target replacement and remote maintenance.
Fully self-developed process
Accelerators, target stations, and separation processes are optimized together to reduce costs.
Copyable Extension
Capable of multi-point deployment, supporting regional medical isotope supply.